Header Logo

Connection

Paolo Gattuso to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications Paolo Gattuso has written about Drug Resistance, Neoplasm.
Paolo Gattuso
Connection Strength
0.051
Drug Resistance, Neoplasm
  1. Prolylcarboxypeptidase promotes IGF1R/HER3 signaling and is a potential target to improve endocrine therapy response in estrogen receptor positive breast cancer. Cancer Biol Ther. 2022 Dec 31; 23(1):1-10.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.